News

CADTH Appoints Director, CADTH Common Drug Review and Optimal Use of Drugs

CADTH is pleased to announce the appointment of Trevor Richter as Director, CADTH Common Drug Review (CDR) and Optimal Use of Drugs, effective October 10, 2016.

Reporting to Brent Fraser, Vice-President of Pharmaceutical Reviews, Trevor will be responsible for CADTH’s non-oncology drug reviews and recommendations, as well as drug-related optimal use projects.

Trevor joined CADTH in 2010 as a Clinical Research Officer, and was quickly promoted to Clinical Research Manager. While at CADTH, Trevor has expanded his health technology assessment and drug review experience by completing assignments with our health economics and medical device portfolios.

Trevor holds a PhD in neuroscience from the University of Cambridge and an MSc in physiology from the University of Pretoria.